Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1821-1830 of 2933 for cancer

Edit search filters
  1. PD 0332991 And Anastrozole For Stage 2 Or 3 Estrogen Receptor Positive And HER2 Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Evaluate The Safety And Immunological Effect Of Pembrolizumab In Resectable Or Borderline Resectable Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  3. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone In Patients With Platinum Sensitive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. 177Lu-PSMA-617 Vs. Androgen Receptor-directed Therapy In The Treatment Of Progressive Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

  5. Study Of Trastuzumab Deruxtecan, Pembrolizumab, And Platinum-based Chemotherapy In First-line HER2 Overexpressing Non-small Cell Lung Cancer

    Rochester, MN

  6. The Role Of Highly Selective Androgen Receptor (AR) Targeted Therapy In Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. Safety And Tolerability Of TAR-200 In Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit For Radical Cystectomy

    Scottsdale/Phoenix, AZ

  8. Testing The Addition Of Total Ablative Therapy To Usual Systemic Therapy Treatment For Limited Metastatic Colorectal Cancer, The ERASur Study

    Scottsdale/Phoenix, AZ

  9. Acetylcysteine Rinse In Reducing Saliva Thickness And Mucositis In Patients With Head And Neck Cancer Undergoing Radiation Therapy

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Veliparib And Floxuridine In Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer